Skip to main navigation Skip to search Skip to main content

A Phase III Randomized Study of Oral Sapacitabine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Project: Research

Project Details

StatusFinished
Effective start/end date01/20/12 → 12/19/17

Funding

  • Cyclacel Limited: $32,463.00